GlassScriptPhysician profile
Alan J Watanabe
NPI 1518961507
$2,172.46
in general payments reported to CMS, 2019-2025
37 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $836 · 2020: $101 · 2021: $11.56 · 2022: $284 · 2023: $387 · 2024: $399 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $903 · Education: $37.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $902.50 |
| Education | $37.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $267.79 | 2019-2024 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $198.56 | 2019-2024 | Mounjaro, Trulicity, Zepbound |
| Glaxosmithkline, LLC. | $177.91 | 2019-2024 | Shingrix, Arexvy |
| Amgen INC. | $149.01 | 2019-2024 | Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $144.54 | 2019-2025 | Farxiga |
| Inari Medical, INC. | $130.23 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $99.99 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $95.91 | 2019-2023 | |
| Abbvie INC. | $92.15 | 2019-2025 | |
| Amarin Pharma, INC. | $70.00 | 2019-2020 | |
| Abbott Laboratories | $59.92 | 2022-2025 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $53.35 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.16 | 2022-2025 | Jardiance |
| Insulet Corporation | $47.64 | 2024 | Omnipod |
| Astellas Pharma US INC | $43.27 | 2019 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Watanabe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.